These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy. Ali S, O'Boyle G, Mellor P, Kirby JA. Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001 [Abstract] [Full Text] [Related]
5. [Chemokines a hope of specific anti-inflammatory treatment]. Schedvins P, Hjelmström P. Lakartidningen; 2002 Mar 07; 99(10):1056-9. PubMed ID: 12024779 [Abstract] [Full Text] [Related]
6. The chemokine network: a target in cancer biology? Slettenaar VI, Wilson JL. Adv Drug Deliv Rev; 2006 Oct 01; 58(8):962-74. PubMed ID: 16996642 [Abstract] [Full Text] [Related]
7. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. Yu X, Huang Y, Collin-Osdoby P, Osdoby P. J Bone Miner Res; 2004 Dec 01; 19(12):2065-77. PubMed ID: 15537451 [Abstract] [Full Text] [Related]
8. Anti-chemokine small molecule drugs: a promising future? Proudfoot AE, Power CA, Schwarz MK. Expert Opin Investig Drugs; 2010 Mar 01; 19(3):345-55. PubMed ID: 20113217 [Abstract] [Full Text] [Related]
9. Chemokine blockers--therapeutics in the making? Wells TN, Power CA, Shaw JP, Proudfoot AE. Trends Pharmacol Sci; 2006 Jan 01; 27(1):41-7. PubMed ID: 16310864 [Abstract] [Full Text] [Related]
10. Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection. Thomas LH, Friedland JS, Sharland M. Expert Rev Anti Infect Ther; 2007 Jun 01; 5(3):415-25. PubMed ID: 17547506 [Abstract] [Full Text] [Related]
15. Microbial corruption of the chemokine system: an expanding paradigm. Pease JE, Murphy PM. Semin Immunol; 1998 Jun 01; 10(3):169-78. PubMed ID: 9653043 [Abstract] [Full Text] [Related]
16. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis. Haringman JJ, Oostendorp RL, Tak PP. Expert Opin Emerg Drugs; 2005 May 01; 10(2):299-310. PubMed ID: 15934868 [Abstract] [Full Text] [Related]
17. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis. Vielhauer V, Anders HJ, Schlöndorff D. Semin Nephrol; 2007 Jan 01; 27(1):81-97. PubMed ID: 17336691 [Abstract] [Full Text] [Related]